Clinical Trial Update: A Dose Finding Study of CpG in Patients With Chronic Lymphocytic Leukemia Who Have Been Previously Treated [Phase 1]

View source ↗

Summary

A Phase 1 dose-finding study evaluated CpG in previously treated patients with Chronic Lymphocytic Leukemia; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• CpG (CpG oligodeoxynucleotide)

Snippet

Sponsor: University of Iowa | Conditions: Chronic Lymphocytic Leukemia | Phase 1 | Status: COMPLETED